Loading...
Back to narrative

Analysts Lift CVS Group Valuation Following Improved Growth and Dividend Announcement

Update shared on 21 Oct 2025

Fair value Increased 6.37%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
39.7%
7D
-2.7%

Analysts have raised their price target for CVS Group from £15.44 to £16.43, citing improved revenue growth and profit margin expectations as key drivers for the upward revision.

What's in the News

  • The Board of CVS Group plc has recommended a final dividend payment of 8.5p per Ordinary share, an increase from 8.0p in 2024 (Key Developments).
  • The final dividend is subject to shareholder approval at the Annual General Meeting scheduled for 18 November 2025 (Key Developments).
  • Key dates have been set: the ex-dividend date is 6 November 2025, the record date is 7 November 2025, and the dividend payment date is 5 December 2025 (Key Developments).

Valuation Changes

  • Fair Value has increased from £15.44 to £16.43, reflecting a higher intrinsic valuation of CVS Group.
  • Discount Rate remains unchanged at 6.82%, indicating ongoing stability in risk assumptions.
  • Revenue Growth has risen slightly from 5.13% to 5.42%.
  • Net Profit Margin has improved from 6.63% to 6.81%.
  • Future P/E has edged higher from 26.0x to 26.5x, signaling modestly higher market expectations.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.